Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Thrombosis and Haemostasis|May 11, 1999
Tissue factor reduction and tissue factor pathway inhibitor release after heparin administrationA M Gori, G Pepe, M Attanasio, et al.Journal of Endocrinological Investigation|August 11, 2020
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal menE Maseroli, P Comeglio, C Corno, et al.Journal of Endocrinological Investigation|January 24, 2022
Testosterone positively regulates vagina NO-induced relaxation: an experimental study in ratsI Cellai, S Filippi, P Comeglio, et al.Journal of Endocrinological Investigation|February 15, 2021
Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit modelP Comeglio, E Sarchielli, S Filippi, et al.American Journal of Medical Genetics. Part A|April 9, 2009
Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterionL Faivre, G Collod-Beroud, B Callewaert, et al.Journal of Medical Genetics|March 4, 2008
Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probandsL Faivre, G Collod-Beroud, A Child, et al.European Journal of Human Genetics : EJHG|November 13, 2008
Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutationL Faivre, G Collod-Beroud, B Callewaert, et al.American Journal of Human Genetics|August 19, 2007
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international studyL Faivre, G Collod-Beroud, B L Loeys, et al.Pageof 4